Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
September 2021 Investor Forum
21st Sep 2021
Incanthera Ltd
September 2021 Investor Forum
21st Sep 2021
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
34: Investing in early-stage science companies | Lucius Cary of Oxford Technology
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Fidelity European Trust Plc
Financials
FEV: follow the money
By
Mark Thomas
21 Sep 2021
City of London Investment Group
Financials
Results full of cash
By
Dr Brian Moretta
20 Sep 2021
Stay up-to-date with the latest research
Sign up to our newsletter
Cizzle Biotechnology/Bould
Life Sciences
Strategic collaboration with SGSC
By
Dr Martin Hall
20 Sep 2021
Fidelity China Special Situations Plc
Financials
China growth story + market-beating style
By
Mark Thomas
20 Sep 2021
Diurnal Group Plc
Life Sciences
All set for three pivotal trials
By
Dr Martin Hall
16 Sep 2021
ICG Enterprise Trust
Investment Companies
ICGT in personal pensions: do as the professionals do
By
Mark Thomas
14 Sep 2021
Oakley Capital Investments
Investment Companies
1H’21: 35% EBITDA growth drives 26% NAV return
By
Mark Thomas
13 Sep 2021
Neodecortech
Consumer
Business booming
By
Jason Streets
13 Sep 2021
Renewables
The REIFs’ Fundraising Record
By
Nigel Hawkins
09 Sep 2021
Yew Grove REIT plc
Property
Strong results, strong prospects
By
Mike Foster
09 Sep 2021
BBGI Global Infrastructure
Infrastructure
Boring is beautiful – and dividend growth continues
By
Nigel Hawkins
07 Sep 2021
1
2
3
...
53
Next
